Who are MMS Plus's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vitamin A + Zinc, Micronutrient without zinc, Micronutrient with zinc.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/mms-plus.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

MMS Plus — Competitive Intelligence Brief

MMS Plus (MMS Plus) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Micronutrient supplement. Area: Nutrition / Public Health.

phase 3 Micronutrient supplement Nutrition / Public Health Small molecule Live · refreshed every 30 min

Target snapshot

MMS Plus (MMS Plus) — Aga Khan University. MMS Plus is a micronutrient supplementation formulation designed to address multiple micronutrient deficiencies simultaneously.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
MMS Plus TARGET	MMS Plus	Aga Khan University	phase 3	Micronutrient supplement
Vitamin A + Zinc	Vitamin A + Zinc	National Institute of Allergy and Infectious Diseases (NIAID)	marketed	Micronutrient supplement combination
Micronutrient without zinc	Micronutrient without zinc	All India Institute of Medical Sciences	phase 3	Micronutrient supplement
Micronutrient with zinc	Micronutrient with zinc	All India Institute of Medical Sciences	phase 3	Micronutrient supplement	Zinc-dependent enzymes and metalloproteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Micronutrient supplement class)

All India Institute of Medical Sciences · 2 drugs in this class
Aga Khan University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MMS Plus — Competitive Intelligence Brief. https://druglandscape.com/ci/mms-plus. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab